Related Experiment Video
Updated: Jun 1, 2026

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
First- and second-trimester fetal size and asthma outcomes at age 10 years
Steve Turner1, Nanda Prabhu, Peter Danielan
1Academic Child Health, Obstetrics and Gynaecology, University of Aberdeen, Royal Aberdeen Children’s Hospital, Foresterhill, Aberdeen, UK. s.w.turner@abdn.ac.uk
Insights
Smaller fetal size in early pregnancy is linked to a higher risk of childhood asthma and poorer lung function. These associations, including eczema risk, persist into later childhood.
Area of Science:
- Pediatric respiratory health
- Fetal development and long-term outcomes
- Epidemiology of allergic diseases
Background:
- Early fetal size is correlated with reduced asthma risk and enhanced lung function in young children.
- Existing research suggests a link between prenatal development and later respiratory health.
- The persistence of these associations into later childhood requires further investigation.
Purpose of the Study:
- To determine if associations between early fetal size and asthma symptoms/lung function persist into later childhood.
- To investigate the relationship between fetal growth patterns and respiratory health outcomes at age 10.
- To explore the association between fetal size and the development of allergic diseases.
Main Methods:
- Longitudinal study design tracking fetal measurements from the first and second trimesters.
- Respiratory questionnaires administered at 10 years of age.
- Subset of participants underwent spirometry, bronchial challenge testing, and skin-prick testing for detailed phenotyping.
Main Results:
- A 1 mm increase in first-trimester fetal size correlated with a 6% reduction in asthma risk and a 6 ml increase in FEV1.
- Reduced first-trimester size was observed in children with asthma at both 5 and 10 years.
- Persistent low fetal growth was linked to increased asthma risk (OR 2.8) and reduced FEV1 (mean 103 ml), while increasing fetal size was associated with higher eczema risk (OR 2.5).
Conclusions:
- Reduced fetal size in the first trimester is a significant predictor of increased asthma risk and impaired lung function in childhood.
- The relative change in fetal size after the first trimester is associated with an increased risk of eczema.
- These findings highlight the long-term impact of early fetal development on respiratory and allergic health.
Rationale:
Greater early fetal size is associated with reduced asthma risk and improved lung function in early childhood.
Objectives:
To test the hypothesis that associations between early fetal size, asthma symptoms, and lung function persist into later childhood.
Methods:
In a longitudinal study, first- and second-trimester fetal measurements were recorded. At 10 years of age a respiratory questionnaire was completed. Spirometry, bronchial challenge, and skin-prick testing were undertaken in a subset.
Measurements And Main Results:
Fetal measurements were available in the first trimester for 853 individuals and the second trimester for 1,453. Questionnaires were returned for 927 children and 449 underwent detailed phenotyping. For each millimeter increase in first trimester size, asthma risk reduced by 6% (95% confidence interval[CI], 1–11) and FEV1 was higher by an average of 6 ml (95% CI, 1–11).First-trimester size was reduced in those with asthma at both 5 and 10 years compared with early or late onset wheeze (P , 0.02). Compared with persistent high growth in first and second trimesters,persistent low growth was associated with increased asthma risk(odds ratio, 2.8; 95% CI, 1.2–6.9) and a mean reduction in FEV1 of 103 ml (95% CI, 13–194), whereas increasing fetal size was associated with increased eczema risk (odds ratio, 2.5; 95% CI, 1.2–5.3).
Conclusions:
Reduced fetal size from the first trimester is associated with increased risk for asthma and obstructed lung function in childhood. Relative change in size after the first trimester is associated with eczema.
Related Concept Videos
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma I: Introduction
Asthma-I: Introduction
Asthma III: Clinical Manifestations
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
